Clinical Trial

Testing Treatment for Breast Cancer

Study Description

Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)

REaCT-RETT will demonstrate the non-inferiority of concurrent compared to sequential endocrine therapy in patients receiving post-operative radiotherapy for early stage breast cancer.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Combination Product - Endocrine Therapy and Radiotherapy

Endocrine therapy and radiotherapy administered either concurrently or sequentially

Additional Information

Official Study Title

A Pragmatic Randomised, Multicentre Trial Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)

Clinical Trial ID

NCT03948568

ParticipAid ID

dPNAAa